KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

CareDx (CDNA) Shares Repurchased (2018 - 2025)

CareDx's Shares Repurchased history spans 5 years, with the latest figure at $12.2 million for Q4 2025.

On a quarterly basis, Shares Repurchased changed N/A to $12.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $87.8 million, a 16713.79% increase, with the full-year FY2025 number at $87.8 million, up 16713.79% from a year prior.
Shares Repurchased hit $12.2 million in Q4 2025 for CareDx, down from $25.6 million in the prior quarter.
Over the last five years, Shares Repurchased for CDNA hit a ceiling of $50.0 million in Q2 2025 and a floor of $67000.0 in Q2 2023.
Historically, Shares Repurchased has averaged $12.9 million across 4 years, with a median of $814000.0 in 2023.
Biggest five-year swings in Shares Repurchased: surged 3945.17% in 2023 and later dropped 24.35% in 2024.
Tracing CDNA's Shares Repurchased over 4 years: stood at $642000.0 in 2022, then surged by 3945.17% to $26.0 million in 2023, then plummeted by 97.99% to $522000.0 in 2024, then surged by 2238.12% to $12.2 million in 2025.
Business Quant data shows Shares Repurchased for CDNA at $12.2 million in Q4 2025, $25.6 million in Q3 2025, and $50.0 million in Q2 2025.